Horm Metab Res 2009; 41(8): 626-629
DOI: 10.1055/s-0029-1216359
Humans, Clinical

© Georg Thieme Verlag KG Stuttgart · New York

Low Serum Adiponectin Predicts 10-Year Risk of Type 2 Diabetes and HbA1c Independently of Obesity, Lipids, and Inflammation: Whitehall II Study

A. G. Tabák 1 , 2 , E. J. Brunner 1 , M. A. Miller 3 , S. Karanam 3 , P. G. McTernan 3 , F. P. Cappuccio 3 , D. R. Witte 1 , 4
  • 1Department of Epidemiology and Public Health, University College London, London, UK
  • 2Semmelweis University, Budapest, Hungary
  • 3Clinical Sciences Research Institute, Warwick Medical School, Coventry, UK
  • 4Steno Diabetes Center, Gentofte, Denmark
Further Information

Publication History

received 26.11.2008

accepted 02.03.2009

Publication Date:
15 April 2009 (online)

Abstract

Our aim of the present work was to study the effect of serum adiponectin on incident diabetes and HbA1c values. We measured baseline serum adiponectin levels in a nested case-control selection (n=140) of the Whitehall II Cohort. Participants (mean [SD] age 50.9 [6.3] years) had no prevalent diabetes or CHD at baseline. Cases (n=55) had incident diabetes according to an oral glucose tolerance test during follow-up (mean: 11.5±3.0 years). Adiponectin levels were lower among cases (9.3 μg/ml, 3.2 [median; IQR] vs. 10.5; 3.6, p=0.01). The risk of incident diabetes decreased by 11% (p=0.03) for 1 μg/ml higher adiponectin levels. Higher adiponectin levels were associated with lower HbA1c at follow-up (p<0.05). Both associations were stable to adjustment for age, sex, body mass index, systolic blood pressure, and serum lipids, and for the case of HbA1c, also for C-reactive protein (all p<0.05). The observed robust, prospective associations support that adiponectin is an independent predictor of diabetes and the degree of glycaemic impairment.

References

  • 1 Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue – an update.  Horm Metab Res. 2007;  39 314-321
  • 2 Oh DK, Ciaraldi T, Henry RR. Adiponectin in health and disease.  Diabetes Obes Metab. 2007;  9 282-289
  • 3 Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study.  Diabetes Care. 2003;  26 2015-2020
  • 4 Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study.  Diabetes. 2004;  53 2473-2478
  • 5 Koenig W, Khuseyinova N, Baumert J, Meisinger C, Lowel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany.  J Am Coll Cardiol. 2006;  48 1369-1377
  • 6 Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.  Diabetes Care. 2003;  26 1745-1751
  • 7 Mather KJ, Funahashi T, Matsuzawa Y, Edelstein S, Bray GA, Kahn SE, Crandall J, Marcovina S, Goldstein B, Goldberg R. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program.  Diabetes. 2008;  57 980-986
  • 8 Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G, Funahashi T, Matsuzawa Y, Shimomura I, Dekker JM. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the Hoorn study.  Diabetes Care. 2006;  29 2498-2503
  • 9 Wannamethee SG, Lowe GD, Rumley A, Cherry L, Whincup PH, Sattar N. Adipokines and risk of type 2 diabetes in older men.  Diabetes Care. 2007;  30 1200-1205
  • 10 Marmot M, Brunner E. Cohort Profile: the Whitehall II study.  Int J Epidemiol. 2005;  34 251-256
  • 11 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Diabetes Care. 1997;  20 1183-1197
  • 12 Kumari M, Head J, Marmot M. Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study.  Arch Intern Med. 2004;  164 1873-1880
  • 13 De Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells.  Clin Diagn Lab Immunol. 2003;  10 133-139
  • 14 Koebnick C, Roberts CK, Shaibi GQ, Kelly LA, Lane CJ, Toledo-Corral CM, Davis JN, Ventura EE, Alexander K, Weigensberg MJ, Goran MI. Adiponectin and leptin are independently associated with insulin sensitivity, but not with insulin secretion or beta-cell function in overweight Hispanic adolescents.  Horm Metab Res. 2008;  40 708-712
  • 15 Thamer C, Haap M, Heller E, Joel L, Braun S, Tschritter O, Haring H, Fritsche A. Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes.  Horm Metab Res. 2006;  38 178-182

Correspondence

A. G. TabákMD 

Department of Epidemiology and Public Health

University College London

1-19 Torrington Place

London WCE1 6BT

UK

Phone: +44/20/7679 17 28

Fax: +44/20/7419 67 32

Email: a.tabak@ucl.ac.uk